Why the study?
Do small, dense LDL particles predict cerebro- and cardio-vascular events in subjects with metabolic syndrome?
Do small, dense LDL particles predict cerebro- and cardio-vascular events in subjects with metabolic syndrome?
Elevated small, dense LDL is an independent predictor of cardiovascular and cerebrovascular events in patients with metabolic syndrome, beyond traditional risk factors.
No takes yet. Share an insight, caveat, or question.
Should not yet change practice in metabolic syndrome; hypothesis-generating for targeted intervention trials.
Rizzo et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: